The Future of Drug Development: AI’s Role in Revolutionizing the Industry

Conversations in Drug Development

In this episode of Conversations in Drug Development, Dr. Julie Warner and Harriet Edwards discuss the revolutionizing role of artificial intelligence (AI) in drug development, exploring its applications in data analysis and toxicity prediction, and its potential to reduce animal testing. Join us in this conversation, as we discuss the challenges of regulating AI in this rapidly evolving field and the need for collaboration between regulators and developers. Is AI pushing the boundaries of what's possible?

To discuss this episode of Conversations in Drug Development with a member of the team, visit www.boydconsultants.com.